Cell Point Complete Financial Statements
In FYNone, Cell Point (CELLPOINT) reported revenue ₹148 Cr, net profit ₹3 Cr and EPS ₹2.10. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse CELLPOINT institutional holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
CELLPOINT Revenue, Net Profit & EBITDA — Year-on-Year Growth
CELLPOINT YoY (March 2026 vs Period) — revenue -59.8%, expenses -61.5%. For live price, earnings ratios and company overview, see CELLPOINT screener.
CELLPOINT Income Statement — Revenue, EBITDA & Net Profit
Cell Point revenue ₹148 Cr, EBITDA ₹10 Cr, net profit ₹3 Cr, EPS ₹2.10 (None). Also explore CELLPOINT price movement history to track price trends across different timeframes.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 148 | 368 | 326 | 323 | 297 | 270 | 224 | 278 |
| Expenses | 138 | 358 | 317 | 313 | 278 | 259 | 215 | 268 |
| EBITDA | 10 | 10 | 9 | 10 | 19 | 12 | 8 | 10 |
| Operating Profit Margin % | 3.00% | 3.00% | 2.00% | 3.00% | 6.00% | 4.00% | 3.00% | 3.00% |
| Depreciation | 1 | 3 | 3 | 2 | 1 | 1 | 1 | 2 |
| Interest | 5 | 6 | 5 | 6 | 9 | 8 | 6 | 6 |
| Profit Before Tax | 5 | 1 | 3 | 3 | 10 | 2 | 1 | 2 |
| Tax | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 |
| Net Profit | 3 | 0 | 2 | 2 | 7 | 2 | 1 | 2 |
| Earnings Per Share (₹) | 2.10 | 0.03 | 1.21 | 0.97 | 4.93 | 1.21 | 6.08 | 14.06 |
CELLPOINT Balance Sheet — Assets, Liabilities & Shareholders' Equity
CELLPOINT total assets ₹169 Cr, total equity ₹74 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 169 | 138 | 134 | 95 | 83 | 65 | 56 |
| Current Assets | 86 | 79 | 71 | 60 | 50 | 32 | 31 |
| Fixed Assets | 60 | 37 | 33 | 18 | 19 | 19 | 19 |
| Capital Work in Progress | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Investments | 66 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 101 | 101 | 76 | 64 | 46 | 37 |
| LIABILITIES | |||||||
| Total Liabilities | |||||||
| Current Liabilities | 32 | 2 | 2 | 19 | 20 | 24 | 22 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 74 | 74 | 72 | 20 | 13 | 12 | 11 |
| Share Capital | 19 | 19 | 19 | 14 | 1 | 1 | 1 |
| Reserves & Surplus | 56 | 56 | 53 | 6 | 12 | 11 | 10 |
CELLPOINT Cash Flow Statement — Operating, Investing & Financing
Cell Point operating cash flow ₹-1 Cr, investing ₹2 Cr, financing ₹-7 Cr, net cash flow ₹-6 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | -1 | -7 | 6 | 0 | 2 | 2 |
| Investing Activities | 2 | -31 | -3 | -1 | -1 | -1 |
| Financing Activities | -7 | 39 | -1 | 6 | 0 | 1 |
| Net Cash Flow | -6 | 2 | 2 | 5 | 1 | 1 |